3 ASX 200 shares for beginners to buy with $500

Here are a few shares that analysts think could be top buys right now.

| More on:
A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investing in the share market can feel overwhelming for beginners, but it doesn't have to be.

A smart way to start is by buying high-quality ASX 200 shares that offer strong growth potential and resilience over the long term.

Even with just $500, you can begin building a diversified portfolio and take advantage of the power of compounding to grow your wealth.

Here are three top ASX 200 shares that are rated as buys by analysts and could be great picks for beginners.

Goodman Group (ASX: GMG)

The first ASX 200 share for beginners to look at is Goodman Group. It is a leading global property company that develops and manages industrial real estate, including warehouses, data centres, and logistics hubs. With the rise of e-commerce, the artificial intelligence megatrend, and the increasing need for efficient supply chains, demand for its properties has been skyrocketing. This has underpinned consistently strong earnings growth for many years.

The good news is that analysts at Citi believe this trend can continue. So much so, the broker recently put a buy rating and $40.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that could be a top pick for beginners is ResMed. It is a medical device company with a focus on sleep apnoea, respiratory care, and digital health.

With millions of people worldwide suffering from sleep disorders, demand for ResMed's products continues to grow. And the good news is that ResMed has a strong and sustainable competitive advantage thanks to its focus on innovation and its significant investment in research and development. This bodes well for the future and leaves it perfectly positioned to capture a growing share of its huge and expanding market.

Goldman Sachs is very positive about its outlook. In fact, this week the broker added ResMed's shares to its conviction list with a buy rating and $49.00 price target.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX 200 share for beginners to consider buying. It is a leading cloud-based accounting software provider, primarily serving small and medium-sized businesses (SMBs). The company has expanded rapidly across Australia, New Zealand, and global markets, providing businesses with an easy-to-use, subscription-based platform to manage their finances.

Looking ahead, as more businesses shift to digital solutions, Xero is well-positioned to capitalise on this trend. The company also has a strong track record of expanding its services and increasing customer spend, which bodes well for future growth.

Goldman Sachs is also a big fan of Xero. It estimates that it has a 100 million+ SMB market opportunity to grow into over the coming decade. As a result, Goldman has a buy rating and $201.00 price target on its shares.

Should you invest $1,000 in Goodman Group right now?

Before you buy Goodman Group shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Goodman Group wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A man looking at his laptop and thinking.
Growth Shares

What I'd buy with $2,000 on the ASX right now

Here are three options for investors to look at this month.

Read more »

Silhouette of CEO standing in conference room looking out at cityscape
Growth Shares

3 founder-led ASX 200 shares with serious long-term upside

Let's see what makes these shares top picks according to analysts.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Growth Shares

Where to invest $5,000 in ASX 200 shares in May

Analysts think that these shares could be top picks for Aussie investors next month.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Growth Shares

3 fantastic ASX growth shares to buy with $2,000 in May

Analysts think these shares would be top picks for growth investors right now.

Read more »

A man points at a paper as he holds an alarm clock.
Growth Shares

3 ASX 200 stocks to buy and hold forever without thinking twice

Here's why these shares could be great buy and hold options for investors.

Read more »

A person with a round-mouthed expression clutches a device screen and looks shocked and surprised.
Growth Shares

3 unstoppable ASX growth shares to buy and hold for the long term

Analysts have good things to say about these top stocks.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

Top Australian stocks for a $7,000 investment today

These stocks are highly rated by analysts. Let's find out why.

Read more »

Two doctors give the thumbs up to an x-ray
Growth Shares

Down 9% in a month! The ASX200 growth stock I'm watching

This healthcare stock could be a buy low option. 

Read more »